ENOV vs IRMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

ENOV

50.0
AI Score
VS
ENOV Wins

IRMD

31.3
AI Score

Investment Advisor Scores

ENOV

50score
Recommendation
HOLD

IRMD

31score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric ENOV IRMD Winner
Forward P/E 5.0839 41.1523 ENOV
PEG Ratio 1.8989 4.46 ENOV
Revenue Growth 3.2% 0.3% ENOV
Earnings Growth 153.1% -9.3% ENOV
Tradestie Score 50.0/100 31.3/100 ENOV
Profit Margin -48.0% 26.7% IRMD
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL ENOV

Relative Price Performance (Last 90 Days)

ENOV 1M: -21.6% · 3M: -8.3% IRMD 1M: -6.4% · 3M: -15.0%

Current Technical Phase

ENOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 34.9 · Price: $19.36

IRMD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.2%), weak momentum, RSI 28

RSI (14): 27.9 · Price: $81.80

Fundamentals Snapshot

Metric ENOV IRMD
Market Cap
Forward P/E 5.0 34.0
Trailing P/E 47.2
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.6% 0.8%
Operating Margin 0.0% 0.3%
EPS -18.35 1.77
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, ENOV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.